Device type · JLW
Radioimmunoassay, Thyroid-Stimulating Hormone
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JLW
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
17
510(k), De Novo and PMA
Adverse event reports
123
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Radioimmunoassay, Thyroid-Stimulating Hormone
- Product code
- JLW
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1690
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JLW
Latest FDA decisions
The 8 newest of 17 since 2015.
Siemens Healthcare Diagnostics, Inc.
K251543 · Decided Feb 6, 2026 · 262 days after receipt
Device type: Radioimmunoassay, Thyroid-Stimulating Hormone (JLW) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics
K243570 · Decided Apr 25, 2025 · 158 days after receipt
Device type: Radioimmunoassay, Thyroid-Stimulating Hormone (JLW) · Laboratory Medicine & Pathology
K234091 · Decided Jul 22, 2024 · 209 days after receipt
Device type: Radioimmunoassay, Thyroid-Stimulating Hormone (JLW) · Laboratory Medicine & Pathology
14 more FDA decisions with a free account
Reports received
123
Received Nov 1, 2025 to Nov 19, 2026. Includes 9 of another or unstated type.
Malfunction reports
111
90% of reports
Injury reports
3
2.4% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 13 | 0 | 0 | 0 |
| Jan 24 | 11 | 0 | 0 | 0 |
| Feb 24 | 20 | 0 | 0 | 0 |
| Mar 24 | 17 | 0 | 0 | 0 |
| Apr 24 | 27 | 0 | 0 | 0 |
| May 24 | 12 | 0 | 0 | 0 |
| Jun 24 | 10 | 1 | 0 | 0 |
| Jul 24 | 17 | 1 | 0 | 0 |
| Aug 24 | 4 | 1 | 0 | 0 |
| Sep 24 | 18 | 1 | 0 | 0 |
| Oct 24 | 11 | 0 | 0 | 0 |
| Nov 24 | 7 | 0 | 0 | 0 |
| Dec 24 | 11 | 0 | 0 | 0 |
| Jan 25 | 8 | 0 | 0 | 0 |
| Feb 25 | 8 | 0 | 0 | 0 |
| Mar 25 | 17 | 0 | 0 | 0 |
| Apr 25 | 17 | 0 | 0 | 0 |
| May 25 | 10 | 0 | 0 | 0 |
| Jun 25 | 9 | 0 | 0 | 0 |
| Jul 25 | 6 | 0 | 0 | 0 |
| Aug 25 | 2 | 0 | 0 | 0 |
| Sep 25 | 8 | 0 | 0 | 0 |
| Oct 25 | 8 | 0 | 0 | 0 |
| Nov 25 | 6 | 0 | 0 | 0 |
| Dec 25 | 5 | 0 | 0 | 0 |
| Jan 26 | 19 | 1 | 0 | 0 |
| Feb 26 | 5 | 0 | 0 | 0 |
| Mar 26 | 9 | 0 | 0 | 0 |
| Apr 26 | 13 | 1 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 5 | 0 | 0 | 0 |
| Jul 26 | 2 | 0 | 0 | 5 |
| Aug 26 | 3 | 0 | 0 | 0 |
| Sep 26 | 13 | 1 | 0 | 0 |
| Oct 26 | 30 | 0 | 0 | 4 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott33
4 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results60
- High Test Results48
- Imprecise or Erratic Results7
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions115
- Insufficient Information7
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Thyroid TSH TestOpen, Classified
Z-0752-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- DxI 9000 Access Immunoassay Analyzer, Part Number C11137Open, Classified
Z-0216-2026 · Started Sep 19, 2025 · Posted by FDA Oct 21, 2025
Reason given: Beckman Coulter has confirmed a software anomaly on DxI 9000 Access Immunoassay Analyzer and the DxC 500i Clinical Analyzer that may prevent correct application of user-specified manual dilution factors when ordering additional tests for samples already "In Progress" using the same "Sample ID number". This can lead to...
Cause as FDA categorized it: Software design
- DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software version 1.20Open, Classified
Z-1913-2025 · Started Apr 23, 2025 · Posted by FDA Jun 5, 2025
Reason given: A new software update (v1.20) is introducing error codes for the Dxl 9000 which prevents the assay from being performed and a delay in results from being generated, and may require field service to resolve the delay.
Cause as FDA categorized it: Software design
43 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.